The downstream targets of SIRT1 include p53 [45, 46], telomerase [43], YAP (Yes-associated protein) [47], and PTEN/PI3K/Akt [48, 49] signaling, all of which can promote HCC progression. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.